Bank Of New York Mellon Corp Ironwood Pharmaceuticals Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$10.37 - $12.56 $13.1 Million - $15.9 Million	1,265,953 New	1,265,953 $13.3 Billion
Q4 2022 Feb 14, 2023	BUY	$9.9 - $12.43 $12.5 Million - $15.7 Million	1,266,626 New	1,266,626 $15.7 Million
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $296,017 - $361,409	-29,193 Reduced 1.75%	1,636,872 $17 Million
Q2 2022 Aug 15, 2022	BUY	$11.05 - $12.72 $6.54 Million - $7.52 Million	591,516 Added 55.05%	1,666,065 $19.2 Million
Q1 2022 May 11, 2022	BUY	$10.61 - $12.88 $2.06 Million - $2.5 Million	194,261 Added 22.07%	1,074,549 $13.5 Million
Q4 2021 Feb 11, 2022	BUY	$10.86 - $13.95 $947,122 - $1.22 Million	87,212 Added 11.0%	880,288 $10.3 Million
Q3 2021 Nov 12, 2021	SELL	$11.92 - $13.92 $314,401 - $367,153	-26,376 Reduced 3.22%	793,076 $10.4 Million
Q2 2021 Aug 11, 2021	SELL	$10.16 - $13.11 $1.79 Million - $2.31 Million	-176,378 Reduced 17.71%	819,452 $10.5 Million
Q1 2021 May 13, 2021	BUY	$9.04 - $11.86 $1.67 Million - $2.19 Million	184,454 Added 22.73%	995,830 $11.1 Million
Q4 2020 Feb 09, 2021	BUY	$9.05 - $12.2 $1.44 Million - $1.95 Million	159,543 Added 24.48%	811,376 $9.24 Million
Q3 2020 Nov 12, 2020	SELL	$8.99 - $10.74 $149,440 - $178,531	-16,623 Reduced 2.49%	651,833 $5.86 Million
Q2 2020 Aug 12, 2020	BUY	$9.14 - $11.97 $158,112 - $207,069	17,299 Added 2.66%	668,456 $6.9 Million
Q1 2020 May 06, 2020	SELL	$8.58 - $14.01 $249,060 - $406,682	-29,028 Reduced 4.27%	651,157 $6.57 Million
Q4 2019 Feb 14, 2020	BUY	$8.22 - $14.0 $117,472 - $200,074	14,291 Added 2.15%	680,185 $9.05 Million
Q3 2019 Nov 07, 2019	BUY	$8.59 - $10.96 $135,567 - $172,970	15,782 Added 2.43%	665,894 $5.72 Million
Q2 2019 Aug 12, 2019	BUY	$9.8 - $12.89 $441,147 - $580,243	45,015 Added 7.44%	650,112 $7.11 Million
Q1 2019 May 14, 2019	SELL	$8.27 - $12.73 $46,775 - $72,000	-5,656 Reduced 0.93%	605,097 $8.19 Million
Q4 2018 Feb 11, 2019	SELL	$7.8 - $16.13 $121,789 - $251,853	-15,614 Reduced 2.49%	610,753 $6.33 Million
Q3 2018 Nov 09, 2018	BUY	$14.31 - $17.65 $153,360 - $189,155	10,717 Added 1.74%	626,367 $0
Q2 2018 Aug 06, 2018	SELL	$11.83 - $16.2 $107,002 - $146,529	-9,045 Reduced 1.45%	615,650 $11.8 Million
Q1 2018 May 15, 2018	BUY	$11.13 - $13.63 $57,230 - $70,085	5,142 Added 0.83%	624,695 $9.64 Million
Q4 2017 Feb 09, 2018	BUY	$12.16 - $14.58 $7.53 Million - $9.03 Million	619,553	619,553 $9.29 Million

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

Black Rock Inc. New York, NY

22.9M
Shares

$80.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

22M
Shares

$77.8 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

16.4M
Shares

$57.9 Million
16.75% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.3M
Shares

$39.8 Million
0.11% of portfolio
State Street Corp Boston, MA

9.92M
Shares

$35 Million
0.0% of portfolio

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account